9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Anti‐Inflammatory and Anti‐Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Acute ocular chemical burns are ophthalmic emergencies requiring immediate diagnosis and treatment as they may lead to permanent impairment of vision. The clinical manifestations of such burns are produced by exacerbated innate immune response via the infiltration of inflammatory cells and activation of stromal fibroblasts. New therapies are emerging that are dedicated to repair mechanisms that improve the ocular surface after damage; for example, transplantation of stem cells (SC) has been successfully reported for this purpose. The pursuit of easily accessible, noninvasive procedures to obtain SC has led researchers to focus on human tissues such as amniotic membrane. Human amniotic mesenchymal SC (hAM‐MSC) inhibits proinflammatory and fibrotic processes in different diseases. hAM‐MSC expresses low levels of classical MHC‐I and they do not express MHC‐II, making them suitable for regenerative medicine. The aim of this study was to evaluate the effect of intracameral injection of hAM‐MSC on the clinical manifestations, the infiltration of inflammatory cells, and the activation of stromal fibroblasts in a corneal alkali‐burn model. We also determined the in vitro effect of hAM‐MSC conditioned medium (CM) on α‐SMA + human limbal myofibroblast (HLM) frequency and on release of neutrophil extracellular traps (NETs). Our results show that intracameral hAM‐MSC injection reduces neovascularization, opacity, stromal inflammatory cell infiltrate, and stromal α‐SMA + cells in our model. Moreover, in in vitro assays, CM from hAM‐MSC decreased the quantity of α‐SMA + HLM and the release of NETs. These results suggest that intracameral hAM‐MSC injection induces an anti‐inflammatory and anti‐fibrotic environment that promotes corneal wound healing. S tem C ells T ranslational M edicine 2018;7:906–917

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

          Mesenchymal stem cells or multipotent stromal cells (MSCs) isolated from the bone marrow of adult organisms were initially characterized as plastic adherent, fibroblastoid cells with the capacity to generate heterotopic osseous tissue when transplanted in vivo. In recent years, MSCs or MSC-like cells have been shown to reside within the connective tissue of most organs, and their surface phenotype has been well described. A large number of reports have also indicated that the cells possess the capacity to transdifferentiate into epithelial cells and lineages derived from the neuroectoderm. The broad developmental plasticity of MSCs was originally thought to contribute to their demonstrated efficacy in a wide variety of experimental animal models of disease as well as in human clinical trials. However, new findings suggest that the ability of MSCs to alter the tissue microenvironment via secretion of soluble factors may contribute more significantly than their capacity for transdifferentiation in tissue repair. Herein, we critically evaluate the literature describing the plasticity of MSCs and offer insight into how the molecular and functional heterogeneity of this cell population, which reflects the complexity of marrow stroma as an organ system, may confound interpretation of their transdifferentiation potential. Additionally, we argue that this heterogeneity also provides a basis for the broad therapeutic efficacy of MSCs.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells.

            Placental tissue draws great interest as a source of cells for regenerative medicine because of the phenotypic plasticity of many of the cell types isolated from this tissue. Furthermore, placenta, which is involved in maintaining fetal tolerance, contains cells that display immunomodulatory properties. These two features could prove useful for future cell therapy-based clinical applications. Placental tissue is readily available and easily procured without invasive procedures, and its use does not elicit ethical debate. Numerous reports describing stem cells from different parts of the placenta, using nearly as numerous isolation and characterization procedures, have been published. Considering the complexity of the placenta, an urgent need exists to define, as clearly as possible, the region of origin and methods of isolation of cells derived from this tissue. On March 23-24, 2007, the first international Workshop on Placenta Derived Stem Cells was held in Brescia, Italy. Most of the research published in this area focuses on mesenchymal stromal cells isolated from various parts of the placenta or epithelial cells isolated from amniotic membrane. The aim of this review is to summarize and provide the state of the art of research in this field, addressing aspects such as cell isolation protocols and characteristics of these cells, as well as providing preliminary indications of the possibilities for use of these cells in future clinical applications.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Concise review: mesenchymal stem cells and translational medicine: emerging issues.

              Mesenchymal stem cells (MSCs) are emerging as a promising therapeutic approach of cell-based therapy for a wide range of autoimmune disorders and degenerative diseases. In preclinical and clinical studies, MSCs have been shown to be highly efficient in treating graft-versus-host disease, systemic lupus erythematosus, multiple sclerosis, type 1 diabetes, myocardial infarction, liver cirrhosis, inflammatory bowel disease, and other disorders. The underlying therapeutic mechanisms of MSCs include their homing efficiency to the tissue injury sites, their differentiation potential, their capability to produce a large amount of trophic factors, and their immunomodulatory effect. Because tissue damage sites are complicated milieus with distinct types of inflammatory cells and factors, available data have demonstrated that the properties of MSCs could be fundamentally influenced by the inflammatory elements. Thus, an understanding of the interaction between MSCs and the inflammatory microenvironment will provide critical information in revealing the precise in vivo mechanisms of MSC-mediated therapeutic effects and designing more practical protocols for clinical use of these cells.
                Bookmark

                Author and article information

                Contributors
                yogarfias@institutodeoftalmologia.org , ygarfias@bq.unam.mx
                Journal
                Stem Cells Transl Med
                Stem Cells Transl Med
                10.1002/(ISSN)2157-6580
                SCT3
                Stem Cells Translational Medicine
                John Wiley & Sons, Inc. (Hoboken, USA )
                2157-6564
                2157-6580
                10 September 2018
                December 2018
                : 7
                : 12 ( doiID: 10.1002/sct3.2018.7.issue-12 )
                : 906-917
                Affiliations
                [ 1 ] Research Unit, Cell and Tissue Biology Institute of Ophthalmology Conde de Valenciana Mexico City Mexico
                [ 2 ] Department of Cornea and Refractive Surgery Institute of Ophthalmology Conde de Valenciana Mexico City Mexico
                [ 3 ] Laboratorio de Inmunorregulación, Departamento de Inmunología Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional Col Santo Tomás Mexico
                [ 4 ] Faculty of Medicine, Department of Biochemistry Universidad Nacional Autónoma de México Mexico City Mexico
                Author notes
                [*] [* ]Yonathan Garfias, M.D., Ph.D., Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autónoma de México. Av. Universidad 3000, C.P. 04510, Mexico City, Mexico. Instituto de Oftalmologia Mexico.52 (55) 5623 2168; e‐mail: yogarfias@ 123456institutodeoftalmologia.org ; ygarfias@ 123456bq.unam.mx
                [†]

                Contributed equally.

                Author information
                https://orcid.org/0000-0003-3753-1035
                Article
                SCT312395
                10.1002/sctm.18-0042
                6265633
                30260581
                c08f4b73-8d0c-4b96-9c30-fad232281c7d
                © 2018 The Authors. stem cells translational medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 28 February 2018
                : 28 July 2018
                Page count
                Figures: 7, Tables: 2, Pages: 12, Words: 9836
                Funding
                Funded by: Conde de Valenciana Foundation
                Funded by: UNAM‐PAPIIT‐DGAPA
                Award ID: IN215617
                Funded by: CONACYT
                Award ID: Problemas Nacionales 311
                Award ID: CIENCIA BASICA‐167438
                Categories
                Tissue Engineering and Regenerative Medicine
                Translational Research Articles and Reviews
                Tissue Engineering and Regenerative Medicine
                Custom metadata
                2.0
                sct312395
                December 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.3 mode:remove_FC converted:30.11.2018

                ham‐msc,corneal repair,α‐sma myofibroblasts,nets,inflammation

                Comments

                Comment on this article